Become a Member

What’s the “Personalized Medicine” Pick teased by Extreme Fortunes?

Checking out Paul Mampilly's latest teaser pitch for 1,000% gains

By Travis Johnson, Stock Gumshoe, February 9, 2017

Paul Mampilly is out with a new promo for his Extreme Fortunes newsletter, making this absurd promise:

“Anyone who joins my research service Extreme Fortunes, and invests $10,000 following my recommendations, will have the chance to earn a profit of $100,000… in the next year.”

So before we begin, let’s throw away that possibility. You’re not going to be able to think clearly about a stock if you go in with that kind of lottery-ticket mentality — and $10,000 is a lot more money than you would probably put into buying lottery tickets. Stocks do sometimes make 1,000% returns, though it’s extremely rare for it to be in a single year… and that promise implies that if you invest $10,000 into his basket of stocks or array of recommendations throughout the year you’ll have a chance at $100,000 in profits.

Some of those stocks are going to go down or provide very small returns, that’s just the nature of investing, so that means he has to have at least one pick that provides something far more dramatic, like 3,000-5,000% returns. (Alternately, if he said investing $120,000 a year, $10,000 into each pick each month, would present the possibility of one of those investments returning $100,000, the promise would be a little more rational but far less enticing).

But the newsletter publisher has something going for him: he knows that if Paul picks a stock that goes up 70%, subscribers will be delighted and will forget that they were promised 1,000% returns… and he also knows that while they’re promising those returns, they are NOT offering refunds on this newsletter, for any reason… so I’m not exactly sure what it is that’s behind that promise, other than Mampilly’s belief (probably sincere, I’ll give him the benefit of the doubt) that he can turn $10,000 into $100,000 for you.

But then they put “Paul’s Track Record” in the ad, and that makes it a bit more clear — it looks like he’s just adding up the percentage returns from each investment and somehow magically making it look like that’s your investment return. So to cherry pick the best gains he claims, back in January (of last year, presumably) he recommended Coeur Mining, which gave him a 738.87% gain, the GDX ETF, which returned 106.8%, and NVIDIA, which returned 108.56%…. and the ad implies that you can add that 738.87 to 106.8 and 108.56 and somehow turn that into a 950% return. That’s not how percentages work.

Those are great trades, of course, assuming that you could actually make them in real life (the CDE trade, for example, means you bought on his recommendation on January 15, 2016 and then sold at the absolute peak on August 9 for a ~740% return — people almost never sell at the peak and I don’t know when he might have recommended a sale … if you held to today, that return would be more like 400%)…

… but even making that trade perfectly doesn’t get you even close to having a 1,000% return on your investments with Paul Mampilly — just use the example he’s offering today of a $10,000 investment that he says he can turn into $100,000 within the year. If you had $10,000 to invest in those three stocks last January, and divided it equally, you would, according to the ad’s return calculations, end up with roughly $27,900 in CDE, $6,900 in GDX, and $6,950 in NVDA. That’s $41,500. So that’s a lovely return of 315% on your $10,000 investment in January, and a gain probably made in only about a half a year, so that’s worth celebrating… but it’s not the far more dramatic 950%+ return that they claim (they actually claim 1,124.71%, but that’s adding on picks made in May and June and July last year which returned anywhere from 3.5% to 44%). The math isn’t made up, but it’s misleading.

So ratchet your expectations down a little bit, and then we’ll go into looking at the actual “Extreme Fortunes” stocks they’re recommending today. It’s never good to count on 1,000% short-term returns, but it is possible to make huge gains on stocks that are selected well, particularly if you have a lot more time than that… and sometimes Mampilly does choose good stocks (though not always, of course) — right now he’s riding on some attention here in Gumshoedom because he has been banging the table for STMicroelectronics (STM) since late last Spring and that stock has indeed done quite well (and, to be fair, I didn’t like STM when he was teasing it and I don’t like it now, so I’ve missed those returns personally).

That STM pitch was for Mampilly’s less expensive $79 “entry level” Profits Unlimited letter, and when you’ve got some investors who are excited about a good pick or few you’ve made the time is ripe to hit them up for “my even better ideas” — at a much richer price, naturally. So Extreme Fortunes is now being pitched as the “upgrade” letter for $2,995 (no refunds).

Mampilly then runs through a long list of stocks that his strategy would, after “rigorous backtesting” using the “DNA of stocks that are primed to jump,” have identified as potential 1,000% winners. But those aren’t actually stocks he recommended — he has had successful picks, of course, as have all newsletter pundits, but he’s not satisfied with those claims of gains of 355%, 634%, or even 2,539% in Sarepta Therapeutics, which is the example he keeps coming back to — he has to imply that somehow he would, using the system he’s suggesting today, also have found multi-year 1,000%+ (or even 10,000%+) winners in past years.

Always be skeptical of “my system would have found these gems back then and made you rich, if only we had discovered this fantastic system and shared it with you then” claims — identifying AMZN as a 50,000% winner in retrospect is easy, but it was far more difficult to pick it in the late 1990s, or even after the dot com crash (would you have have sold AMZN when it was dropping by 90% in 2001? If so, you missed a lot of that potential return), and it was more difficult still to stick with it for long enough to generate those absurdly high 50,000% returns. Backtesting makes fortune-making look easy — and backtesting that doesn’t include the possibility that some of the stocks that satisfy your backtest criteria probably lost 50% or 80% or 99% is disingenuous (the “system” itself uses pretty loose criteria, at least as described in the ad, so you could probably use it to claim almost anything you want).

So what are those criteria? What is it that Mampilly says he’s looking for? He says his “DNA” for stocks that are “primed to rally 1,000%” includes a few steps:

First, he says you need to find out “if the company is an industry disruptor” — here’s how he puts it:

“Finding disruptors is one of the foundational pillars of grabbing a 1,000% gain.

“This could be a new drug, new technology, a new system for doing things, a new medical device… the list is endless.

“But it has to disrupt the industry.

“And — this is key — I pay close attention to the potential market size for this disruptive company.

“If the potential market is small, the stock can only climb so much. But if it has a big potential market, the stock can easily climb 1,000%.”

That’s nothing shocking for growth investors, of course — that’s what David Gardner at the Motley Fool calls “Rule Breakers” stocks, and a lot of them fail… but the big winners do, like Amazon or Netflix or Priceline, generate staggering returns.

“Phase II is the number-crunching phase. Once I know a company is going to disrupt an industry, I need to make sure it has the potential to go up 1,000%.

“I look at a lot of numbers. Some are really basic.

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


“For example, I want lower-priced stocks. Generally, I look for stocks that are priced between $1 and $25. Above that, and the odds of the stock going up tenfold diminish quickly….

“I also want companies with a market cap of $150 million to $3 billion. They still have a lot of room to go up….

“I want to find companies that currently have under $3 billion in sales, while growing sales an average of 10% to 20% a year.

“At this rate, a company would double its sales within five years … something which — without fail — catapults the stock price.”

And then he says that his other key criteria is “Insider Activity” — here’s how he puts it:

“Specifically, I look at insider buying and selling.

“If the C-level executives of a company don’t own a good portion of their own stock, I don’t want to touch it. Full stop….

“Insiders need to have millions of their own dollars at stake.”

So those are the criteria — small cap stock, low-priced, insider ownership, sales growth… what, then, is the one stock he focuses on as the big buy to lure in investors? Here’s how he introduces it:

“This is the most excited I’ve been about an investment in years. I expect people will be talking about this company decades from now, just as much as they talk about Pfizer in pharmaceuticals. It has all the makings of being a mega-sized company… and just like all those companies, anyone prudent enough to be there, at the ground-floor, stands to make money hand over fist in the months ahead….

“This company is at the heart of a relatively new science … a science already disrupting one of the largest markets … health care.

“It’s called precision medicine.”

What other clues do we get? Here’s what I culled out of the ad for you:

“Early-stage firms have already reaped huge returns — like Illumina, which is up 3,000% so far.

“But the real winner is emerging at this very moment … the company I am going to share with our viewers today. This company is specifically planning to dominate the precision treatment of cancer … positioning it for the $107 billion haul for cancer treatment in the short term…

“In fact, the Swiss pharmaceutical giant Roche just invested $1 billion in this company….

“I project sales to soar 70% by the end of this year, it has a market cap under $1 billion and the stock is priced under $25….

“… in the last year, insider ownership has doubled….

“The Roche purchase woke a sleeping giant … Wall Street.

“Kleiner, Perkins, Caufield and Byers — one of the largest venture capital firms in Silicon Valley — has now taken a large stake in this firm…

“Institutional giants like BlackRock, Vanguard and Oppenheimer quickly followed.

“I expect this company could move very, very quickly. Again, small stocks mean increased volatility, so those following my recommendations should be aware of the risk, keep the buy-up-to price in mind and avoid ‘chasing the stock’ too far.”

OK, so that is a fairly easy pile to chew on for the Mighty, Mighty Thinkolator — we’ll have to use the electric start during this snowy weather, but I got it chugging along pretty nicely, shoveled the whole pile in for you, and got the answer out right quick: This is Foundation Medicine (FMI).

Foundation Medicine is indeed a “personalized medicine” stock, focused on cancer treatment, and it fits all Mampilly’s criteria — it has a market cap of about $850 million, is growing revenue at about 15%, and has a huge investment from Roche (Roche spent about a billion dollars to get a majority stake two years ago — that sent the stock flying, since Roche paid a huge premium for that controlling stake, but it fell back down starting a few months later and has spent most of the past 18 months bouncing between $15-25… it’s at the top of that range right now, and it appears to me that it’s probably Paul Mampilly’s pressure driving it up, since the stock has climbed about 25% in two days.

I don’t know whether the company’s fundamentals mean it should be trading at this $25 price, but I don’t see any fundamental change between Monday and today, and it was trading at $19 on Monday… so in these kinds of situations it’s always important to be a bit wary. Buying pressure doesn’t necessarily keep stocks moving up forever, particularly if it’s just buying pressure from a newsletter recommendation… that newsletter will move on and recommend different stocks, or the pundit might even suggest a sell at some point, you never know. Or maybe it’s the beginning of a massive blaze of enthusiasm, and the fire has just been lit — I tend on the side of skepticism after these kinds of pops, but I don’t know the stock well.

Analysts are predicting continued revenue growth for FMI, but not anything that will be in danger of tipping them over into profitability anytime soon — they’re expected to lose $3 a share when they report in about two weeks, and another $3 a share in 2017 and $2 a share in 2018 on 20%ish revenue growth. They have already pre-announced 2016 numbers, in a press release that came out on January 9 and had little to no impact on the share price, so it seems silly to count on the earnings providing a positive surprise beyond that.

And the company also noted that this year, as they transition to a new CEO, they have the following non-financially-specific outlook:

“As part of Foundation Medicine’s commitment to being a partner for the patient journey, the company expects to advance a number of key business objectives in 2017. These include: advancing its universal, pan-cancer companion diagnostic assay through the FDA and CMS parallel review process to decision and launch in the second half of 2017; broadening Medicare and third-party payer coverage for its clinical CGP products; growing clinical volume across its product portfolio, including expanded global market presence; and expanding its biopharma business, including additional companion diagnostic collaborations and SmartTrials clinical trial access programs.”

The business essentially develops and sells genetic tests (comprehensive genomic profiling, CGP). These are used both in testing patients and identifying strains of cancer, and in making assessments about which treatment is best for which variety of tumor a patient might have. That is certainly an interesting business, though I don’t know what the competition is like or whether FMI is likely to see their market share in the testing business balloon because of any specific tests they’re hoping to roll out this year.

And with that, I’ll leave you to it — it’s not a stock I’m buying, but the Roche investment is an important foundation for the shares and they do have positive trends in terms of sales and testing volume so there is a real business that is improving… whether that means it’s worth the $600 million market cap it had before Roche invested a couple years ago, or the $500 million it fell to a year ago, or the $850 million it popped to this week when it hit $25 a share, I have no idea — that’s a lot of volatility for a company whose numbers do not change all that much, and which is nowhere near profitability even with pretty solid revenue growth projected, so you’ll have to make your own call. Let us know what you think with a comment below.

P.S. On the “insider ownership” bit FMI has been hit or miss over the past few years — they do have some substantial insider ownership, though it pales compared to Roche’s giant stake, but there has not been any buying over the past six months, just the (fairly typical) steady stream of relatively small sales from insiders. Having insider owners in itself is generally “a good thing,” all else being equal, though if you’re looking for the impact on shares the only real academic research into this indicates that the only thing that indicates a stock has a better chance of rising is when multiple C-suite insiders buy shares with their own money (i.e., not just getting a grant of stock or stock options that don’t cost them anything). Having employees who buy stock is far more compelling as a “tell” for possible good things happening than having employees who are given stock as part of their compensation.

Irregulars Quick Take

Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)
guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

326 Comments
Inline Feedbacks
View all comments
texasxx
texasxx
February 9, 2017 2:44 pm

Any guesses on the other ones? I know there is less to work with, but I did find this article which I believe relates to the second pick:

https://www.nytimes.com/2016/06/30/business/dealbook/google-capital-ventures-into-public-companies-with-carecom.html

This stock shared a jump in price similar to FMI.

“The second stock is the eBay of health care, which has already disrupted how we approach caring for our family members, our pets, even our homes. Google has already invested $46 million into this company…

The third stock is a little-known superstar in the Internet of Things revolution. I haven’t told any of my subscribers about this stock yet. Consumers don’t know about this company, but mega caps like Delta, Boeing, Coca-Cola, McDonald’s, Intel and Wells Fargo have been throwing money at it … doubling its sales in just three years.

The fourth company is a rising pharmaceutical superstar. As you know, Viagra … Nuvigil … Provigil … Cialis … are just a few of the “lifestyle” drugs that produced multibillion-dollar sales funnels for Pfizer, Cephalon, United Therapeutics and others. Now a new drug is entering the market … and it’s currently without a contender. Sales have already skyrocketed 119% in just a year … and are expected to jump another 76%. This is enormous, as Wall Street still doesn’t realize the potential of this new drug and how much money it will make this pharmaceutical company.

The fifth stock is a silver play I’ve been eyeing for over a year. This stock has the potential to eclipse the Coeur Mining trade that handed me a 738% gain.”

Add a Topic
5971
Add a Topic
5971
Add a Topic
163
👍 -2
👍 21718
ripvanwinkle2061
ripvanwinkle2061
May 10, 2017 9:12 pm
Reply to  texasxx

Yes, it’s Care.com and the internet of things is most likely STM.

Lammaster
February 9, 2017 3:28 pm

Thanks Travis, I am truly getting worn out with all of this pitching, if you bought into most of these you would be out at least 10k before you even made a penny. For those of us who aren’t well to due and don’t have the time to sit and analyze the stock market all day and want to try and improve our net worth, is there any one you like of these guys who win more often than not, or is that a silly question? PS I have doubled my money on STm!

Add a Topic
5971
👍 21718
lam master
February 9, 2017 5:43 pm

Another silly question, how reliable are Bolinger bands and RSI?

tropicanaoj
tropicanaoj
February 9, 2017 3:40 pm

Appreciate the logical and timely breakdown, Travis. These sales pitches continue to entice even the most disciplined of us.

👍 7
thinairmony
February 9, 2017 7:33 pm
Reply to  tropicanaoj

tropicanaoj that’s what Travis and his gem of a virtual $tockGumshoe magizine does, he keeps us who read it well grounded to the reality of the real world. Another Great Disection!

frank_n_steyn
Irregular
February 9, 2017 3:42 pm

I don’t know if anyone caught it, but some of the past “investments” on the pitch were not actual trades, but were backtested possibilities, if one was using his system, as in “could have mades”.

👍 471
👍 21718
thinairmony
February 9, 2017 7:37 pm

Very true. I tried it with Z**ks. A day to day exhausting tasks.

stock006
stock006
February 9, 2017 4:30 pm

I believe the second stock is care.com (CRCM) The mutual funds he mentioned invest in it. Let’s figure out the other 3.

Add a Topic
5971
Add a Topic
334
👍 31
bluedancer
Guest
bluedancer
February 14, 2017 3:36 pm
Reply to  stock006

I believe APRI might be the pharmaceutical one with a topical cream for erectile dysfunction which sits at around $2.70. He gives very little clues on the silver play, but there are lots of companies that will do a margin trade for you on silver. I suggest nothing higher than 4:1 personally, and prepare to hold it as silver is manipulated strongly. Still working on his #3 his superstar of the IoT. I have a few ideas.

Add a Topic
443
Add a Topic
443
Add a Topic
443
Carbon Bigfoot
Guest
Carbon Bigfoot
February 9, 2017 4:53 pm

I’ve been a member of the Sovereign Society for a couple. There were several sub-services that were $$$-ons. Then recently these services were consolidated into Banyan Hill without warning. Then my credit card was debited before the due date on the pretext that I can “lock-in” lifetime rates. I took exception to this action and dropped the services except Jeff Opdyke’s Total Wealth Insider and James Davidson’s Strategic Investment, since there was time left on the subscriptions. Had I shorted the Mexico Peso before the election as Davidson recommended, I would have made 43X my investment!!
I’ve made a little money on two of Opdyke picks.
Then this little Indian Paul Mampilly was introduced as the next best thing to sliced bread, a Wall Street Maverick and then an endless barrage of teases–not for me.
Last year I took a position in Roche, because of FMI but I’m out $600 bucks and only holding on for the dividend payment, hoping to cut my losses and then I’m out. So much for expectations— they never leave room for disappointment.

Add a Topic
5563
Add a Topic
1340
Add a Topic
1682
Brent Eynon
February 13, 2017 1:38 pm
Reply to  Carbon Bigfoot

Easy there, Cowboy…

James Love
Member
James Love
February 9, 2017 5:02 pm

I have owned FMI for some time with the premise that revenue would increase substantially if Medicare would cover the tests provided by FMI. I have been surprised that the stock has not risen in expectation of Medicare approval.

Add a Topic
5971
tropicanaoj
tropicanaoj
February 9, 2017 5:29 pm

Just looking at the volume for FMI and CRCM since Mampilly’s recommendation is astounding. Despite their best efforts, I see these guys having their families/close friends pick up shares prior to the rec and then sell off. I would be interested in deciphering the other three tickers as well!

👍 7
allfie
Member
allfie
February 9, 2017 7:14 pm

MANY thanks!!!! I like shorts… PTM is now 13.6 and I am shorting in looking for 7. Book value is 5.2 many thanks.

archegos2691
archegos2691
February 10, 2017 2:24 am
Reply to  allfie

Allfie, is PTM the stock symbol? or the company it self? I cannot find it.

Add a Topic
5971
👍 35
misterht
Guest
misterht
February 9, 2017 9:24 pm

This guy is making his money off the back of the subscribers and if the stock tanks he’s not going to lose any of his money it seems.

Add a Topic
5971
Hank
Member
Hank
February 9, 2017 9:41 pm

But you are wrong.

Yes, for sure, Mampilly won’t be giving his money back but he appears to be a decent person (my guess) and his FMI pick seems to be as solid a one as I can come up with myself, i.e., in a crowded field with a ton of ‘Johnnie-come-latelies.’

OF COURSE he’s not going to give his money back! That would be absurd. It’s as tough a business as there is–stock picking–your broker won’t be returning his fee either.

There are zero guarantees in life.

My point: either way, PM will earn his pay.

I am more interested in the next two ideas, less interested in his “silver play.”

Add a Topic
372
Add a Topic
443
stock006
stock006
February 9, 2017 10:19 pm

Did anyone come up with his other 3 stock picks?

Add a Topic
5971
👍 31
archegos2691
archegos2691
February 10, 2017 2:27 am
Reply to  stock006

One of the is a “Silver” play. I have been looking at all the Silver stocks to see which one has spiked on Feb 7 or 8….but could not figure it out.

• Silver Wheaton Corp. (TSX: SLW)
• Pan American Silver (NASDAQ: PAAS)
• Fresnillo Plc (LSE: FRES)
• iShares Silver Trust ETF (NYSE: SLV)
• Global X Silver Miners ETF (NYSE: SIL)
• Fresnillo Plc (LSE: FRES)
• Fortuna Silver Mines (TSX: FVI, NYSE: FSM)
• Tahoe Resources (TSX: THO, NYSE: TAHO)
• Great Panther Resources (TSX: GPR)
• Silver Standard Resources (NASDAQ: SSRI)
• Endeavour Silver (AMEX: EXK)
• First Majestic Silver (TSX: FR)\
• CDE – Coeur d’Alene Mines Corp.
• AG – First Majestic Silver Corp.
• HL – Hecla Mining Company
• SVM – Silvercorp Metals Inc.
• EXK – Endeavour Silver Corp.

Add a Topic
443
Add a Topic
443
Add a Topic
443
👍 35
shawn
Guest
shawn
February 12, 2017 7:09 am
Reply to  archegos2691

“The third stock is a little-known superstar in the Internet of Things revolution. I haven’t told any of my subscribers about this stock yet. Consumers don’t know about this company, but mega caps like Delta, Boeing, Coca-Cola, McDonald’s, Intel and Wells Fargo have been throwing money at it … doubling its sales in just three years.”

I mostly play short term earnings and i came across this stock last week PI
Impinj, Inc I believe this may be the third stock hes touting it makes sense i read over the latest SEC filings real quick. I actually really liked this stock. For some reason this Mampillys face keeps haunting me and i come to this website to see whats up. Last time I was here I discovered from your research that he was touting STM at the time it was 8 and change. No I didnt buy it but I have tracked it, and has done well. This is a great site. PI reports thursday I believe its worth watching. It has only been public a few quarters and they have done well. Check it out

Add a Topic
5971
Add a Topic
5971
Add a Topic
4381
Brent Eynon
February 13, 2017 1:49 pm
Reply to  shawn

I don’t think Impinj (PI) is going to be one of the recs in Extreme Profits because Paul has mentioned this stock in one of his email posts. I subscribe to his Profits Unlimited newsletter ’cause it’s cheap, and I like the guy. I’m confident his new high $$ new subscribers would be upset if one of his big “windfalls” is one he’s casually mentioned before.

Add a Topic
5971
Add a Topic
5274
bluedancer
Guest
bluedancer
February 14, 2017 3:47 pm
Reply to  Brent Eynon

PI was my thought as well. I was thinking
his #4 pick might be APRI. Although the % increase does not match up to being 111% in one year. It has doubled since it hit bottom in December though.

bluedancer
Guest
bluedancer
February 14, 2017 4:12 pm
Reply to  bluedancer

Oops the 111% is sales not stock price increase, so yes I am sticking with APRI as this one. Anyone else have thoughts on it?

Add a Topic
5971
curiousjoe
curiousjoe
February 9, 2017 11:39 pm

FMI was pitched by Shah Gilani of Money Map Press and deciphered by Travis a couple of years ago. Established a small position when it was in the 30’s, after which it sold off. Got out with a loss and will be staying away. Stock could be moving up in anticipation of earnings announcement on 02/22.

Add a Topic
2609
Add a Topic
605
Add a Topic
5971
👍 29
Herbert Prater
Member
February 10, 2017 2:20 am

I thought life insurance and used cars was a hard sell until I discovered the Sharks on Wall Street

Add a Topic
1208
Add a Topic
882
hip3434
Member
hip3434
February 10, 2017 11:50 am

Just to chime in here. I am a member of Profits Unlimited and now recently Extreme Fortunes. I was a skeptic in the beginning of PU and missed out on many good recommendations STM being one. I went in after the election and am still making great returns. Apparently, many people in the service share this same sentiment. I think Paul is a good guy and genuinely wants to help people. Of course, only time will tell.

Add a Topic
5274
Add a Topic
5566
Brad Lewis
Guest
Brad Lewis
February 10, 2017 2:39 pm
Reply to  hip3434

I am a member of Profits Unlimited too, but the price of Extreme Fortunes was too much at 3k so i passed. Made money on STM but its all in my 401k with a Self directed brokerage account so i can really touch it for a few more years without penalty. i offered him $250 a month times 12 month and they said no. what are his 5 picks? I figured out the Care.com one out but no the other 4.

Add a Topic
5274
Add a Topic
5566
Brent Eynon
February 13, 2017 1:57 pm
Reply to  hip3434

I agree, but think about it… he’s investing in SOMETHING, just not what he recommends. I’m skeptical that he/they recommend the T-Bones while they eat the Filet. At least Motley Fool (and others) put their money where their mouth is, and just include a disclaimer. Like Brad Lewis, I too called to try to talk them down a bit, but they weren’t even accepting new members to Extreme. “Doors had closed” they said. Add that up… 1,000 members times $3,000 membership. That’s a cool $3M.

Add a Topic
329
YoBrent
YoBrent
February 20, 2017 1:55 pm
Reply to  hip3434

BTW, if you are a member of Extreme Fortunes, then why are you here Reading this pist thread?

Add a Topic
5566
👍 1
backoffice
Irregular
May 23, 2017 8:13 pm
Reply to  YoBrent

Touche!

👍 450
Darryl Bouchard
Member
Darryl Bouchard
February 11, 2017 7:36 am

Do you know what the stock is that the Morgan report talked about on the dollar vigilante recently it has something to do with a patented leaching process that eliminates cyanide…I find your editorials about these newsletter guys so revealing and quite humorous…I mean these sales piches are quite humorous…it’s a wonderful service to those of us who don’t know that much about investing…as they are very compelling…I used to write copy, trained with some of the very best direct response marketers before the internet…so I do read these things and do figure out at times who they are touting…anyway you do a much better job than I do…thanks

Add a Topic
5971
Add a Topic
5642
Eddie22
Guest
Eddie22
February 11, 2017 11:59 am

I also am a Profits Unlimited subscriber and can say that I am very happy I joined back in August. For all of the scrutiny of Paul’s previous STM initiation it has without a doubt been a spot on call. At the time the stock was a risky pick to hang your hat on to say the least but anyone following the recent earnings report last week has to give the man his credit for the intuition and insight. As of today his PU portfolio picks have had gains of (from lowest to highest) -4%, -3%, 0%, 3%, 12%, 17%, 18%, 20%, 29%, 32%, and 41% in an 8 month period. And that doesn’t include the triple digit appreciation of STM in that same time. To me, those are pretty decent returns with the bulk of the upside for these companies yet to come according to Paul. I get that people want to call these services out as a scam or click bait. But as I sit right now these picks have worked out pretty well for me or anyone that has followed his advice.

It remains to be seen what these new extreme fortunes picks will lead to. As with anything in life I find it best to give someone a chance and see if their predictions ring true. It takes a lot of guts to hang your reputation on the line and make the bold claims that Paul is making. But as with the case of the STM thesis, it’s at least worth a listen…

Add a Topic
5274
Add a Topic
5971
Add a Topic
1278
khl
Member
khl
February 11, 2017 5:25 pm
Reply to  Eddie22

I recently subscribed to Paul Mampilly’s Profits Unlimited service and I am in agreement with Eddie22. I have to say he appears to be quite good and professional so far. I am quite impressed with his writing and rationale in his stock recommendations. It is much better than a couple of other newsletters subscribed to in the past like Motley Fool Stock Advisor.

Add a Topic
5274
Add a Topic
5971
Add a Topic
329
LLK
Guest
LLK
May 7, 2017 9:42 pm
Reply to  Eddie22

I joined PU in Feb 2017. I keep making money off his picks. Just like hip3434, I hesitated on some of his picks wanting to just watch them a bit and I missed out on some great profits. I like him. I don’t know about Extreme Fortunes but I’m thinking about it.

Add a Topic
5566
stock006
Guest
stock006
February 11, 2017 9:04 pm

For the third time, did anyone figure out the other 3 stocks that Paul recommended last week on his $2999 package? We have figured out the first two as FMI and CRCM I believe?
He also just offered a lower cost newsletter for $999 rather than $2999. He has 3 secret stocks for joining this too. Any ideas out there? Thanks

archegos2691
archegos2691
February 12, 2017 1:58 am
Reply to  stock006

I did not figure out the other 3 from the 5….but for the new newsletter that he calls True Momentum..i think one of the 3 is USG. Warren Buffett’s Berkshire Hathaway owns 26%

Add a Topic
522
bluedancer
Guest
bluedancer
February 14, 2017 4:03 pm
Reply to  archegos2691

look at APRI… # 4 I believe…

Michael
Michael
February 14, 2017 6:42 pm
Reply to  bluedancer

It probably is not APRI since Paul has a minimum market cap of (I believe) 150 million.

Shyly
Guest
Shyly
February 18, 2017 5:27 pm
Reply to  Michael

I am subscribed to Extreme Fortunes and Profits Unlimited.
So, you’re trying to get the information free? LOL

Add a Topic
5566
Add a Topic
5274
Hank
Member
Hank
February 11, 2017 9:12 pm

No one figured the other three out. And if you keep asking, none of us will ever get any more information. I’d consider not pining so much. Hungry money never wins. Beggars don’t either.

For the record, buying silver here–Sunday night–is interesting. Risky for sure, but silver, the metal, is at a key juncture point.

In other words, you don’t need the ‘silver play.’

Silver is either going up, or its not.

Add a Topic
443
Add a Topic
443
Add a Topic
443
bluedancer
Guest
bluedancer
February 14, 2017 3:59 pm
Reply to  Hank

I thought one of them to be PI and the 4th to be APRI.

bluedancer
Guest
bluedancer
February 14, 2017 4:01 pm
Reply to  bluedancer

“The fourth company is a rising pharmaceutical superstar. As you know, Viagra … Nuvigil … Provigil … Cialis … are just a few of the “lifestyle” drugs that produced multibillion-dollar sales funnels for Pfizer, Cephalon, United Therapeutics and others. Now a new drug is entering the market … and it’s currently without a contender. Sales have already skyrocketed 119% in just a year … and are expected to jump another 76%. This is enormous, as Wall Street still doesn’t realize the potential of this new drug and how much money it will make this pharmaceutical company.” This is APRI with a topical cream for erectile dysfunction, approved in Canada and other countries and awaiting approval in the US. JUST a guess though!

Add a Topic
5256
Add a Topic
1515
Autodidack Somewhere in Vermont
Autodidack Somewhere in Vermont
February 11, 2017 9:42 pm

February 11, 2017

Tonight, I am joining the large cohort of readers who have written to thank you, Travis, for an OUTSTANDING site—a truly educational experience. Since this is the first time that I have stepped into your public forum, a VERY brief bio might be appropriate. Be advised, brothers and sisters of the digital, virtual age, that I am a neophyte student and know next to nothing about investment in securities [you have been forewarned].

My name is Thomas, and I am an erratic, somewhat eccentric and cranky (at times) octogenarian; retired after 50+ year-career as a commercial real property analyst. Lest you become too impressed, reader, please know that my one huge personal investment misstep of a lifetime was in real estate, my area of expertise. To recall such an idiotic stumble still smarts!

As an unsophisticated “investor,” here are some sources, which I have found helpful:

STOCK GUMSHOE … duh! Lucky for me, I stumbled upon this site!
Morningstar [http://www.morningstar.com]
Dan Weiner’s Independent Adviser for Vanguard Investors [http://adviseronline.investorplace.com]
Dan writes solely on Vanguard, has for years, and he tells it like it is—the good, the bad, and the ugly
Richard C. Young’s, Intelligence Report [http://intelligencereport.investorplace.com]

Both Weiner and Young advise that most of us ought to have an investment base in carefully chosen mutual funds. Vanguard is well respected for its integrity and low commission expense. However, as Dan informs, not all Vanguard mutual funds are equal. “Buy the manager,” is ONE of his oft repeated admonitions.

Young advises buying stocks with a history of continuous, increasing dividend distributions over many years. Many other factors about a company inform any investment decision, of course.

THESE HEREIN ABOVE LISTED PERSONS DO NOT HYPE GET RICH QUICK SCHEMES.

I do read a number of so-called investment letters; then i go to—you guessed it—the Gumshoe to find out the real nitty gritty. In the process I learn a WHOLE lot, and from those who comment as well. Thank you everyone.

A few closing thoughts: I have gained much insight from books by James Rickards (and others), and I subscribe to some of Rickards letters; although more recently he begins to feel more and more like a pitch man with some of his more recent promotions. Just saying….

All of us know about the Frontline programs expose’ of the Wall Street miscreants. If you are new to this area of complexity, I strongly suggest that you view these films.

Finally, I reckon that all of us have found a web site or two that inform those of us seeking to understand what in the world the whole financial/economic bubbling cauldron portends for our families and our nation. I very much recommend Paul Volcker’s web site, THE VOLCKER ALLIANCE [https://volckeralliance.org]. Just LOOK at his Board of Directors! Impressive! As an after thought, if I were going to invest in a bank, I might start by researching the interests of Charles Bowsher. He might know a bit about avoiding being blind-sided by derivatives when the roiling tsunami thrashes and trashes whatever tranquility we enjoy.

Thank you, readers, for your many interesting and insightful comments. And thank YOU, Travis.

The Autodidact Lost in Vermont.

Add a Topic
409
Add a Topic
5971
Add a Topic
1823
👍 3

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
34
0
Would love your thoughts, please comment.x
()
x